Expected value of sample information calculations in medical decision modeling.
about
Preventive strategies for group B streptococcal and other bacterial infections in early infancy: cost effectiveness and value of information analysesEstimating multiparameter partial expected value of perfect information from a probabilistic sensitivity analysis sample: a nonparametric regression approachProbabilistic sensitivity analysis in health economics.Methods to assess cost-effectiveness and value of further research when data are sparse: negative-pressure wound therapy for severe pressure ulcers.Economic evaluation of surgical insertion of ventilation tubes for the management of persistent bilateral otitis media with effusion in childrenSurgical treatments for men with benign prostatic enlargement: cost effectiveness study.Evidence synthesis as the key to more coherent and efficient research.Is a comparative clinical trial for breast cancer tumor markers to monitor disease recurrence warranted? A value of information analysisLong term costs and effects of reducing the number of twin pregnancies in IVF by single embryo transfer: the TwinSing study.Estimating expected value of sample information for incomplete data models using Bayesian approximation.Is a HIV vaccine a viable option and at what price? An economic evaluation of adding HIV vaccination into existing prevention programs in ThailandUsing value-of-information methods when the disease is rare and the treatment is expensive--the example of hemophilia A.Economic return from the Women's Health Initiative estrogen plus progestin clinical trial: a modeling study.The STAR trial protocol: a randomised multi-stage phase II/III study of Sunitinib comparing temporary cessation with allowing continuation, at the time of maximal radiological response, in the first-line treatment of locally advanced/metastatic renaDoes more mean less? The value of information for conservation planning under sea level rise.Private manufacturers' thresholds to invest in comparative effectiveness trials.Identifying future research priorities using value of information analyses: left atrial appendage occlusion devices in atrial fibrillation.Development of a transparent interactive decision interrogator to facilitate the decision-making process in health care.Sample Size Estimation for Non-Inferiority Trials: Frequentist Approach versus Decision Theory Approach.Estimating the Expected Value of Sample Information Using the Probabilistic Sensitivity Analysis Sample: A Fast, Nonparametric Regression-Based Method.Agreement of decision analyses and subsequent clinical studies in infectious diseasesCost effectiveness of abdominal aortic aneurysm screening and rescreening in men in a modern context: evaluation of a hypothetical cohort using a decision analytical model.The value of comparative effectiveness research: projected return on investment of the RxPONDER trial (SWOG S1007)HEADROOM APPROACH TO DEVICE DEVELOPMENT: CURRENT AND FUTURE DIRECTIONSShared decision-making based on different features of risk in the context of diabetes mellitus and rheumatoid arthritis.Non-invasive versus invasive management in patients with prior coronary artery bypass surgery with a non-ST segment elevation acute coronary syndrome: study design of the pilot randomised controlled trial and registry (CABG-ACS)Strategies for efficient computation of the expected value of partial perfect information.Computing Expected Value of Partial Sample Information from Probabilistic Sensitivity Analysis Using Linear Regression MetamodelingIntegration of meta-analysis and economic decision modeling for evaluating diagnostic tests.Estimating the expected value of partial perfect information in health economic evaluations using integrated nested Laplace approximationModels based on value and probability in health improve shared decision making.Are value of information methods ready for prime time? An application to alternative treatment strategies for NSTEMI patients.Pressure RElieving Support SUrfaces: a Randomised Evaluation 2 (PRESSURE 2): study protocol for a randomised controlled trial.Value-of-information analysis within a stakeholder-driven research prioritization process in a US setting: an application in cancer genomics.Value of information in the osteoarthritis setting: cost effectiveness of COX-2 selective inhibitors, traditional NSAIDs and proton pump inhibitors.A systematic and critical review of the evolving methods and applications of value of information in academia and practice.Cost-effectiveness and value of information analysis of nutritional support for preventing pressure ulcers in high-risk patients: implement now, research later.Use of value of information in UK health technology assessments.Cost-effectiveness analysis of axitinib through a probabilistic decision model.Interpretation of the Expected Value of Perfect Information and Research Recommendations: A Systematic Review and Empirical Investigation.
P2860
Q24680268-A09CE2BF-789B-4F88-8C2B-A4954A7733DAQ27324994-5EE2398D-3C5C-4D7A-9C1E-F1714D866BB4Q30407247-DF3EAAB8-1B2A-497E-86CE-8105A9D7F25CQ30559593-DA36A94C-6F0F-4246-ABD2-C5EAB06BE6BDQ30585025-29BAEFF4-E861-4561-9591-F68394902A2AQ33431091-803EF331-7EF7-4AD3-855C-4442FB7FF11CQ33437253-4AF85120-4A8F-4C2A-8D07-871BA46C2D7FQ33599906-71F46805-6F80-4754-ADA9-F0CAEBE973E7Q33723461-239E446F-C689-468D-A8C9-F33EC4A9A22FQ33879453-F7BD3400-D2A1-49EC-9F27-843885998476Q33951023-5F0F9B44-B235-4BC3-AAD4-E05DD2ECB0BEQ34011908-B071D416-BA12-449B-ADB5-D8D38A204951Q34147730-0FD85929-BD43-4CAC-BD66-18685BC019AFQ34513318-E98AA15C-6FD6-4B74-ACB6-F8F255621848Q34624943-57061D29-05AB-4062-990F-DBBD3183C644Q35024408-F0B93E2E-5F3D-4BFA-A89E-215BAA81E441Q35070620-29ABE460-A773-424A-A2F0-4C81B58C3504Q35180222-07BAFF6B-7D5B-4AFF-8328-7E6F6D295CCFQ35664152-3EC86EC0-728E-4DFF-8A53-07B4A7F4CE0BQ35752778-CDC9D859-3229-43EF-BB0F-921EEEF06665Q35873919-52C88110-F66D-4E55-A5E7-A0894A66DB06Q36078231-11385908-A600-42BB-9DB9-DA4B73C6E7ACQ36364504-4310524A-B17D-43F9-B04D-BB98461B16CBQ36603368-E6BDA926-0459-450E-8EC3-826756C2023CQ36663691-EA4C4E21-6A35-4910-806D-563F26011474Q36819302-82847C47-45D6-40FD-8701-DE0FB0FA9A86Q37103266-0C3ED2D1-6481-4E8A-90A9-364033B4AC30Q37163118-8F1D8702-1E30-4B24-8B8C-61F6A6217511Q37254814-1204279E-8A21-484B-940F-AEC7228DECAAQ37272487-C66C4087-0EE5-469E-8F45-5788F739DFF4Q37329278-C6F4256E-7213-4746-A849-46EB9B251BBAQ37355389-2E0399E8-F701-4B73-B90D-88B08CE0ACFEQ37517495-51DE99E6-A90C-4026-8671-4793C51A94C4Q37600599-BD076A4E-E6CB-42E8-9EA8-518C2477B2F6Q37808208-BAA20D4D-0179-4492-B96A-44A091452992Q38074914-72E39E59-7D94-4C18-89F0-0D773A80807AQ38343692-32FEEF24-8805-4E8A-A058-013B69402ADAQ38393698-AAA9E8CC-65A2-448F-AC7C-BA61C59EFE55Q38469815-8ABF0C42-D8EF-4736-A81B-B6FE968C1467Q38489282-BD894BE2-9C20-418A-8C67-071E5CD8CC73
P2860
Expected value of sample information calculations in medical decision modeling.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Expected value of sample information calculations in medical decision modeling.
@en
Expected value of sample information calculations in medical decision modeling.
@nl
type
label
Expected value of sample information calculations in medical decision modeling.
@en
Expected value of sample information calculations in medical decision modeling.
@nl
prefLabel
Expected value of sample information calculations in medical decision modeling.
@en
Expected value of sample information calculations in medical decision modeling.
@nl
P2093
P2860
P356
P1476
Expected value of sample information calculations in medical decision modeling.
@en
P2093
P2860
P304
P356
10.1177/0272989X04263162
P577
2004-03-01T00:00:00Z